Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-25

Clinical Trial Update: Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy

View source ↗

Summary

An ongoing trial comparing switching to a long-acting injectable HIV regimen with continuing oral dual or triple integrase-based therapy, assessing HIV reservoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bictegravir (bictegravir)
  • Dolutegravir (dolutegravir)
  • Lamivudine (lamivudine)
  • abacavir (abacavir)
  • cabotegravir (cabotegravir)
  • rilpivirine (rilpivirine)

Snippet

Sponsor: Hôpital Européen Marseille | Conditions: HIV Infections | Status: RECRUITING